Vontobel Holding’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-86,475
Closed -$426K – 1502
2026
Q2
$426K Buy
86,475
+38,364
+80% +$206K ﹤0.01% 1107
2026
Q1
$260K Buy
48,111
+24,490
+104% +$147K ﹤0.01% 1035
2025
Q4
$164K Sell
23,621
-4,745
-17% -$31.2K ﹤0.01% 1328
2025
Q3
$183K Buy
+28,366
New +$194K ﹤0.01% 1241
2021
Q4
– Sell
-9,489
Closed -$264K – 1068
2021
Q3
$264K Sell
9,489
-894
-9% -$25.4K ﹤0.01% 970
2021
Q2
$304K Buy
+10,383
New +$315K ﹤0.01% 912

Other funds holding BHC

Vontobel Holding's BHC Position: Q3 2026 in Review

Vontobel Holding sold out of Bausch Health (BHC) in Q3 2026, closing a stake of 86,475 shares — an estimated $426K sold.

Vontobel Holding first reported a position in BHC in Q2 2021 and held it in 6 quarters. The position peaked at $426K in Q2 2026. 112 funds tracked by Wall St. Rank hold BHC as of Q3 2026.

  • Vontobel Holding reported no remaining Bausch Health position as of Q3 2026 after selling out during the quarter.
  • Vontobel Holding sold 86,475 Bausch Health shares in Q3 2026, an estimated $426K.
  • Vontobel Holding first reported a position in Bausch Health in Q2 2021 and held it in 6 quarters.
  • Vontobel Holding's Bausch Health position peaked at $426K in Q2 2026.
  • 112 funds tracked by Wall St. Rank held Bausch Health as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.